Calippe B, Augustin S, Poupel L, Hu S, Lavalette S, Fauvet A, Rayes J, Levy O, Raoul W, Fitting C, Denèfle T, Pickering MC, Harris C, Jorieux S, Sullivan PM, Sahel JA, Karoyan P, Sapieha P, Guillonneau X, Gautier EL and Sennlaub F, (2017) Complement factor H inhibits CD47-mediated resolution of inflammation, Immunity. 2017;46:261-272
Roumenina LT, Rayes J, Frimat M and Fremeaux-Bacchi V (2016). Endothelial cells: source, barrier, and target of defensive mediators. Immunol Rev. Nov; 274:307-329.
Roumenina LT, Rayes J, Lacroix-Desmazes S and Dimitrov JD (2016), Heme: Modulator of Plasma Systems in Hemolytic Diseases.Trends Mol Med. Mar;22:200-13.
Rayes J & Watson S.P. Platelet GPVI repairs its own damage (2015). Blood. 126:933-4.
Rayes J, Roumenina LT, Dimitrov JD, Repessé Y, Ing M, Christophe O, Jokiranta TS, Halbwachs-Mecarelli L, Borel-Derlon A, Kaveri SV, Frémeaux-Bacchi V, Lacroix-Desmazes S (2014), The interaction between factor H and VWF increases factor H cofactor activity and regulates VWF prothrombotic status. Blood ;123:121-5.
Teyssandier M, Delignat S, Rayes J, Bryckaert M, Jandrot-Perrus M, Kaveri SV, Lacroix-Desmazes S (2012). Activation state of platelet in experimental severe hemophilia A. Haematologica. Jul;97:1115-6.
Rayes J, Hollestelle MJ, Legendre P, Marx I, de Groot PG, Christophe OD, Lenting PJ, Denis CV (2010), Mutation & ADAMTS13-Dependent Modulation Of Disease Severity In A Mouse Model for Won Willebrand Disease Type 2B. Blood. Jun;115:4870-7.
Rayes J, Hommais A, Legendre P, Tout H, Veyradier A, Obert B, Ribba AS, Girma JP (2007), Effect of von Willebrand disease type 2B and type 2M mutations on the susceptibility of von Willebrand factor to ADAMTS-13 , J Thromb Haemost. Feb;5:321-8.
Book chapter: Julie Rayes, Alexander T Hardy, Stephanie E Lombard, Samantha J Montague, Steve P Watson and Kate L Lowe (2017). The role of CLEC-2 in and beyond the vasculature. Book Title :Platelets in Thrombotic and Non-Thrombotic Disorders, Springer pp 129-138
View all publications in research portal